Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hedner (Göteborg, Sweden). Carbon anhydrase inhibitors for treatment of obstructive sleep apnoea. International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: ACE-inhibitors and obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 358s Year: 2005 Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 The role of bi-level therapy in obstructive sleep apnoea Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019 Year: 2019 Erythrocyte production in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Roles of periostin in patients with severe obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Chronic cough in patients with obstructive sleep apnea. Source: International Congress 2018 – Obesity: comorbidities Year: 2018 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Effect of obstructive sleep apnea on asthma control Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001